Capula Management LTD Biogen Inc. Transaction History

Capula Management LTD

  • $9.23 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$275.25 - $318.06 $253,230 - $292,615
920 New
920 $262,000
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $426,623 - $518,356
1,690 New
1,690 $467,000
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $476,277 - $612,086
-2,127 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $601,919 - $784,969
2,127 New
2,127 $602,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email